Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Isentress Gets Unanimous Nod From Advisory Committee, But May Get Limited Indication

This article was originally published in The Pink Sheet Daily

Executive Summary

Discussion of the indication for Merck’s raltegravir centered on whether the HIV therapy should be approved only for the highly treatment-experienced population studied in clinical trials.

You may also be interested in...



Isentress Approval Carries Limited Indication

FDA follows lead of its September Antiviral Drugs Advisory Committee recommendation.

Isentress Approval Carries Limited Indication

FDA follows lead of its September Antiviral Drugs Advisory Committee recommendation.

FDA Review Of Merck’s Novel HIV Drug Isentress Shows No Clear Efficacy Or Safety Concerns

FDA is asking its Antiviral Drugs Advisory Committee at the Sept. 5 meeting to consider HIV general treatment issues and postmarketing strategies for Merck’s integrase inhibitor, Isentress (raltegravir), which is up for accelerated approval.

Topics

UsernamePublicRestriction

Register

PS066685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel